SSEA4 AND ST3GAL2 AS CHEMOTHERAPEUTIC DRUG RESPONSE BIOMARKERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150316556A1
SERIAL NO

14675240

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides the use of the biomarkers SSEA4 and/or ST3GAL2 for assessing the outcome for chemotherapeutic treatment of a cancer in an individual and methods thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XENTECH4 RUE PIERRE FONTAINE GENOPOLE - CAMPUS 3 91000 EVRY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aloia, Andrea Zurich, CH 3 19
Bosio, Andreas Cologne, DE 44 85
Cairo, Stefano Longpont Sur Orge, FR 3 24
Deas, Olivier Gometz La Ville, FR 1 9
Hardt, Olaf Cologne, DE 9 20
Judde, Jean-Gabriel Arcueil, FR 2 21
Petrova, Evgeniya Paris, FR 2 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation